Document is current
Any future updates will be listed below
-
Authors
Ehrencrona, Carolina
Li, Ying
Angenete, Eva
Haglind, Eva
Franzén, Stefan
Grimby-Ekman, Anna
Bock, David
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 3 December 2023
Accepted: 9 April 2024
First Online: 11 April 2024
Declarations
:
: Ethical approvals were obtained from the Regional Ethical Review Boards in Göteborg, Sweden for LAPPRO (Laparoscopic Prostatectomy Robot Open;), (EPN 277–07), for QoliRECT (Quality of Life in Rectal Cancer) in Göteborg, Sweden (EPN 595–11) and Denmark (H-3–2012-FSP26), and for QoliCOL (Quality of Life in Colon Cancer) in Göteborg, Sweden (EPN 957–14) and Denmark (H-16027323). All patients gave informed consent to participate in the studies.
: Not applicable.
: David Bock and Stefan Franzén are currently employees at AstraZeneca, BioPharmaceuticals R&D, Gothenburg, Sweden. The protocol and statistical analysis plan of this study were finalized before they commenced their employment. The other authors have no conflicts of interest to disclose.
